Side Effects of albiglutide injection: A Synthesis of Findings from 9 Studies

  1. Home
  2. Side Effects of albiglutide injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of albiglutide injection: A Synthesis of Findings from 9 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of albiglutide injection: A Synthesis of Findings from 9 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Albiglutide is a new GLP-1 receptor agonist used for the treatment of type 2 diabetes. 6 , 7 , 5 , 2 , 3 , 9 , 4 , 1 , 8 These studies have shown that albiglutide is effective in controlling blood sugar levels and may also help with weight loss. 7 Albiglutide has also been reported to have fewer gastrointestinal side effects compared to other GLP-1 receptor agonists and is safe for use in patients with decreased kidney function. 3 , 1

Reasons for Side Effects

Side effects of albiglutide are thought to be caused by activation of the GLP-1 receptor. 8 GLP-1 receptors are found in the gastrointestinal tract, pancreas, central nervous system, etc. and affect various tissues. 5

Common Side Effects

Gastrointestinal Side Effects

The most common side effects of albiglutide are gastrointestinal side effects. 5 , 2 , 3 , 9 , 4 , 1 Symptoms such as nausea, vomiting, and diarrhea may occur. 5 However, these side effects are usually more common early in treatment and often improve over time. 5 , 4 Albiglutide has also been reported to have fewer gastrointestinal side effects compared to other GLP-1 receptor agonists. 3 , 1

Injection Site Side Effects

Injection site pain, redness, and swelling may occur with albiglutide. 2 , 3 , 9 , 1 These side effects are usually mild and often go away within a short period of time. 1

Other Side Effects

Like other GLP-1 receptor agonists, albiglutide may increase the risk of pancreatitis. 2 , 3 , 1 However, the incidence of pancreatitis is very low, and it usually resolves when albiglutide is stopped. 1

Countermeasures for Side Effects

Gastrointestinal Side Effects

To reduce gastrointestinal side effects, it is recommended to take albiglutide after meals. 5 It is also effective to start with small doses and gradually increase the amount. 5 If symptoms are severe, consult a doctor. 5

Injection Site Side Effects

To reduce injection site side effects, methods such as cooling before injection or warming after injection may be effective. 2 If symptoms are severe, consult a doctor. 2

Comparison between Studies

Commonalities in Studies

Many studies have shown that albiglutide is effective in controlling blood sugar levels. 6 , 7 , 5 , 2 , 3 , 9 , 4 , 1 Albiglutide has also been reported to have fewer gastrointestinal side effects compared to other GLP-1 receptor agonists. 3 , 1

Differences in Studies

The effects and side effects of albiglutide may vary from study to study. 3 For example, the effect on weight loss varies depending on the study. 7 The incidence of pancreatitis also varies depending on the study. 1

Precautions for Application to Real Life

Albiglutide is an effective drug for treating type 2 diabetes, but it is important to remember that there are risks of side effects. 5 , 2 , 3 , 9 , 4 , 1 Before taking albiglutide, consult your doctor to understand the risks and benefits. 5 , 2 , 3 , 9 , 4 , 1

Current Limitations of Research

Research on albiglutide is still insufficient. 1 In particular, there is a lack of research on long-term safety and efficacy. 9 , 1

Future Directions for Research

Research is needed to evaluate the long-term safety and efficacy of albiglutide. 9 , 1 Research is also needed on combination therapy with albiglutide and other drugs. 4

Conclusion

Albiglutide is an effective drug for treating type 2 diabetes. 6 , 7 , 5 , 2 , 3 , 9 , 4 , 1 However, it is important to remember that there are risks of side effects. 5 , 2 , 3 , 9 , 4 , 1 Before taking albiglutide, consult your doctor to understand the risks and benefits. 5 , 2 , 3 , 9 , 4 , 1

Literature analysis of 9 papers
Positive Content
9
Neutral Content
0
Negative Content
0
Article Type
1
0
0
7
9
1.

The safety of albiglutide for the treatment of type 2 diabetes.

Author: RendellMarc S

GI tolerance
Injection site reactions
Pancreatitis

Albiglutide is a long acting GLP-1 receptor agonist (GLP-1 RA) administered by weekly injection. This review discusses the safety of albiglutide, including gastrointestinal side effects, renal safety, and concerns regarding pancreatitis and injection site reactions.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

2.

Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials.

Author: AhrénBo, CarrMolly C, MurphyKaren, PerkinsChristopher, RendellMarc, MalloryJason, WilsonTimothy, JohnsonSusan

No increased nausea/vomiting
Similar AE frequency
Diarrhea risk
Injection site reaction risk
Pancreatitis risk

This review of 7 phase 3 clinical trials examined the safety of albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), in patients with type 2 diabetes mellitus (T2DM). The review found that albiglutide was well-tolerated and had similar rates of adverse events compared to other T2DM medications. However, albiglutide was associated with higher rates of diarrhea and injection-site reactions.

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Albiglutide: a unique GLP-1 receptor agonist.

Author: RendellMarc S

Albiglutide safety
Injection site reactions
Pancreatitis

Albiglutide, a long-acting GLP-1 receptor agonist, has demonstrated a favorable safety profile with fewer gastrointestinal side effects than other GLP-1 RAs. However, it achieves a lower HbA1c reduction and minimal weight loss compared to other GLP-1 RAs. A large long-term study is underway to evaluate its long-term cardiovascular outcomes.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

4.

Novel Therapeutic Approaches in Diabetes.

Author: GallwitzBaptist

Lower blood pressure
Lower hypoglycemia risk
Reduced HbA1c
Weight loss
Fullness
Genital/urinary infections
Nausea

This chapter discusses novel therapeutic approaches for type 2 diabetes, including incretin-based therapies, sodium-glucose transporter-2 inhibitors, and other emerging therapies.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

5.

Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance.

Author: TellaSri Harsha, RendellMarc S

Glucose control
Weight loss
β cell protection
Gastrointestinal side effects

GLP-1 receptor agonists are used to treat diabetes and obesity, lowering hemoglobin A1c by 0.5-1.5% and promoting weight loss of 2-5%. The main side effect is gastrointestinal disturbance, which can lead to discontinuation of treatment.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

7.

Once-weekly albiglutide in the management of type 2 diabetes: patient considerations.

Author: WoodwardHeather N, AndersonSarah L

Type 2 diabetes treatment
Gastrointestinal issues

Albiglutide, a once-weekly injectable glucagon-like peptide-1 receptor agonist, has been approved to improve glycemic control in adults with type 2 diabetes. Albiglutide is generally safe and well-tolerated, with mild gastrointestinal complaints and injection site erythema being the most common side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.